Shanghai-based embodied intelligence company Fourier Intelligence announced on June 18 a multi-million level order deployment in Southeast Asia. The announcement coincided with the official launch of Malaysia's National Social Insurance Organization (PERKESO) rehabilitation center, where Fourier became the core technology provider with its Intelligent Rehabilitation Port, Galileo biomechanics system, and GRx series humanoid robots. CEO Gu Jie told media including The Paper that Chinese companies' overseas expansion now prioritizes trust-building and technical innovation over price competition. The partnership with PERKESO, which began in 2022, represents a multi-year collaboration spanning product application, scientific research cooperation, and joint project development within Malaysia's national rehabilitation framework.
Fourier-PERKESO Partnership Began in 2022 with Multi-Year Trust-Building Process
The collaboration between Fourier and PERKESO started in 2022, progressing through product application, scientific research cooperation, and joint project construction phases. Gu Jie stated that establishing trust foundation is the most difficult aspect, requiring at least two to three years or longer. He noted that ten to twenty years ago, Chinese products were perceived as lacking technical content and quality, but over the past decade Chinese enterprises built trust in Chinese products and underlying technologies through various overseas strategies. According to Gu, companies must demonstrate continuous development, technological progress, and rapid product iteration speed to establish this trust base.
CEO Gu Jie Identifies Trust and Localization as Primary Overseas Challenges
"Chinese companies are no longer playing a simple low-price card, which is completely different from selling small commodities before. Intelligence-building establishes trust, technological innovation, and local technical support, which are the most critical," Gu Jie stated. He identified localization as the second major challenge in overseas expansion, emphasizing that international markets have extremely high requirements for localized technical support and services. The CEO stressed the importance of recruiting local personnel and establishing complete teams capable of rapid pre-sales consultation and after-sales response. Gu noted that with established trust, partners regularly inquire about new products and technological changes.
Three Product Lines Represent Fourier's Ten-Year Development Trajectory
The three products deployed in the PERKESO project reflect Fourier's decade-long evolution. Gu Jie described the Intelligent Rehabilitation Port as representing the company's starting point, when the team focused on learning international advanced technology and developing single products before building complete rehabilitation solutions. The Galileo system represents the growth stage, integrating biomechanics, sports science, and robotics technology to serve both clinical training and scientific research innovation. Gu stated this system demonstrates Fourier's capability to compete and innovate alongside international peers. The humanoid robot represents the future direction, with Fourier exploring embodied intelligence applications in healthcare and elderly care scenarios including cognitive training, assistive care, and long-term health management.
Humanoid Robot Projects Remain in POC Stage with Clinical Validation Required
Gu Jie stated that humanoid robot collaborations are currently in the POC (proof of concept) stage, requiring clinical and localized validation before applying for local registration and compliance certification. He indicated these projects will gradually transition from clinical trials to formal sales. Regarding the industry's anticipated "commercialization breakthrough point," Gu expressed that it will not appear suddenly at a specific time but rather through a gradual process. He projected that in the coming years, humanoid robots will more likely first create value in single-function scenarios such as cognitive training and assistive guidance before expanding to more complex service scenarios. The CEO noted that both domestically and internationally, humanoid robots in medical and elderly care scenarios remain in the application exploration stage.
FAQ
What did Fourier Intelligence announce on June 18?
Fourier Intelligence announced a multi-million level order deployment in Southeast Asia, with the official launch of Malaysia's PERKESO rehabilitation center where the company became the core technology provider with three product lines: Intelligent Rehabilitation Port, Galileo biomechanics system, and GRx series humanoid robots.
When did Fourier's partnership with PERKESO begin?
The partnership between Fourier Intelligence and Malaysia's PERKESO started in 2022, progressing through product application, scientific research cooperation, and joint project development phases over multiple years.
What stage are Fourier's humanoid robot projects currently in?
According to CEO Gu Jie, humanoid robot collaborations are in the POC (proof of concept) stage, requiring clinical and localized validation before applying for local registration and compliance certification to transition from clinical trials to formal sales.
